Genetics of mental retardation;Retards mentaux d'origine génétique

Pathologie Biologie

Volumn 58, Issue 5, 2010, Pages 331-342

  Goldenberg, A ^a,b   Saugier Veber, P ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Chromosome; Gene; Genetic counseling; Mental retardation; Mutation

Indexed keywords

ARTICLE; CHROMOSOME DELETION; CLINICAL EXAMINATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONSULTATION; CYTOGENETICS; DIAGNOSTIC PROCEDURE; FAMILY; FRAGILE X SYNDROME; GENETIC COUNSELING; HOMOCYSTINURIA; HUMAN; KARYOTYPE; MENTAL DEFICIENCY; METABOLIC DISORDER; MYOTONIC DYSTROPHY; PATHOGENESIS; PATIENT CARE; PROGNOSIS; RECURRENCE RISK; RETT SYNDROME; SANFILIPPO SYNDROME; SMITH MAGENIS SYNDROME; WILLIAMS BEUREN SYNDROME;

ABNORMALITIES, MULTIPLE; CHILD; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CYTOGENETIC ANALYSIS; FEMALE; GENETIC COUNSELING; HUMANS; MALE; MENTAL RETARDATION; METABOLISM, INBORN ERRORS; MUTATION; PHENOTYPE; PREVALENCE; SYNDROME;

EID: 77957294852     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.09.013     Document Type: Article

References (41)

1. American Association on Mental Retardation. DSM-IV-R, Diagnosis and Statistical Manual of Mental Disorders. 4th revised edition. Washington, DC; 1994.
2. Sparrow S.S., Balla D.A., Cicchetti D.V. Vineland adaptive behavior scales 1984, American Guidance Service, Circle Pines, MN.
3. Roeleveld N., Zielhuis G.A., Gabreels F. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol 1997, 39:125-132.
4. Stromme P., Valvatne K. Mental retardation in Norway: prevalence and sub-classification in a cohort of 30,037 children born between 1980 and 1985. Acta Paediatr 1998, 87:291-296.
5. Matilainen R., Airaksinen E., Mononen T., Launiala K., Kaariainen R. A population-based study on the causes of mild and severe mental retardation. Acta Paediatr 1995, 84:261-266.
6. Yeargin-Allsopp M., Murphy C.C., Cordero J.F., Decouflé P., Hollowell J.G. Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985 to 1987. Dev Med Child Neurol 1997, 39:142-149.
7. Cans C., Wilhelm L., Baille M.F., du Mazaubrun C., Grandjean H., Rumeau-Rouquette C. Aetiological findings and associated factors in children with severe mental retardation. Dev Med Child Neurol 1999, 41:233-239.
8. Jones K.L., Smith D.W. Smith's recognizable patterns of human malformation 1997, WB Saunders Co, Philadelphia, Pa. 5th edition.
9. Knight S.J., Regan R., Nicod A., Horsley S.W., Kearney L., Homfray T., et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999, 354:1676-1681.
10. Edelmann L., Hirschhorn K. Clinical utility of array CGH for the detection of anomalies. Ann N Y Acad Sci 2009, 1151:157-166.
11. Biancalana V., Beldjord C., Taillandier A., Szpiro-Tapia S., Cusin V., Gerson F., et al. Five years of molecular diagnosis of Fragile X syndrome (1997-2001): a collaborative study reporting 95 % of the activity in France. Am J Med Genet A 2004, 129A:218-224.
12. Lubs H.A. A marker X chromosome. Am J Hum Genet 1969, 21:231-244.
13. Oberlé I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991, 252:1097-1102.
14. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., et al. Fragile X genotype characterized by an instable region of DNA. Science 1991, 252:1179-1181.
15. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
16. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991, 65:1047-1058.
17. Jin P., Warren S.T. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000, 9:901-908.
18. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 1983, 14:471-479.
19. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
20. Huppke P., Laccone F., Krämer N., Engel W., Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 2000, 9:1369-1375.
21. Percy A.K., Lane J.B. Rett syndrome: clinical and molecular update. Curr Opin Pediatr 2004, 16:670-677.
22. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
23. Meola G. Myotonic dystrophies. Curr Opin Neurol 2000, 13:519-525.
24. Wheeler T.M., Thornton C.A. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 2007, 20:572-576.
25. Potocki L., Shaw C.J., Stankiewicz P., Lupski J.R. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 2003, 5:430-434.
26. Elsea S.H., Girirajan S. Smith-Magenis syndrome. Eur J Hum Genet 2008, 16:412-421.
27. Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 2003, 33:466-468.
28. De Leersnyder H., Bresson J.L., de Blois M.C., Souberbielle J.C., Mogenet A., Delhotal-Landes B., et al. Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder. Smith-Magenis syndrome. J Med Genet 2003, 40:74-78.
29. Kotzot D., Bernasconi F., Brecevic L., Robinson W.P., Kiss P., Kosztolanyi G., et al. Phenotype of the Williams-Beuren syndrome associated with hemizygosity at the elastin locus. Eur J Pediatr 1995, 154:477-482.
30. Francke U. Williams-Beuren syndrome: genes and mechanisms. Hum Mol Genet 1999, 8:1947-1954.
31. Tassabehji M. Williams-Beuren syndrome: a challenge for genotype-phenotype correlations. Hum Mol Genet 2003, 12:229-237.
32. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997, 34:798-804.
33. Perez E., Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 2002, 14:678-683.
34. Shprintzen R.J. Velocardiofacial syndrome: 30 years of study. Dev Disabil Res Rev 2008, 14:3-10.
35. Murphy K.C. Schizophrenia and velocardiofacial syndrome. Lancet 2002, 359:426-430.
36. Nidiffer F.D., Kelly T.E. Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study. J Ment Defic Res 1983, 27:185-203.
37. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E., et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985, 37:1-31.
38. De Franchis R., Sperandeo M.P., Sebastio G., Andria G. Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum?. Eur J Pediatr 1998, 157:S67-70. The Italian Collaborative Study Group on Homocystinuria.
39. Gibson K.M., Christensen E., Jakobs C., Fowler B., Clarke M.A., Hammersen G., et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics 1997, 99:567-574.
40. Berry-Kravis E., Hessl D., Coffey S., Hervey C., Schneider A., Yuhas J., et al. A pilot open label, single dose trial of fenobam in adults with Fragile X syndrome. J Med Genet 2009, 46:266-271.
41. Wheeler T.M., Sobczak K., Lueck J.D., Osborne R.J., Lin X., Dirksen R.T., et al. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009, 325:336-339.